Latest News about CRSP
Recent news which mentions CRSP
2 Best Stocks to Invest $5,000 in Right Now
January 01, 2022
From Motley Fool
Vertex Pharmaceuticals Stock: Bull vs. Bear
December 31, 2021
From Motley Fool
7 Stock Bargains Worth a Look After the Most Recent Pullback
December 27, 2021
From InvestorPlace
Top 5 Moonshots for 2022 Countdown: My No. 5 Pick
December 22, 2021
From InvestorPlace
3 Healthcare Stocks to Buy If You're Worried About a Market Crash
December 21, 2021
From Motley Fool
10 Bargain Stocks to Buy After Falling 30% in 2021
December 20, 2021
From InvestorPlace
3 Biotech Stocks That Are Too Cheap to Ignore
December 19, 2021
From Motley Fool
5 Unstoppable Trends to Invest $5,000 In for 2022
December 19, 2021
From Motley Fool
CRISPR Therapeutics Is One of Today’s Best Biotech Value Investments
December 09, 2021
Tickers
CRSP
From InvestorPlace
3 Beaten-Down Biotech Stocks -- Are They Bargains Now?
December 08, 2021
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For December 7, 2021
December 07, 2021
From Benzinga
Why CRISPR Therapeutics Stock Sank 12.5% in November
December 05, 2021
Tickers
CRSP
From Motley Fool
Is Vertex Pharmaceuticals Stock a Buy Now?
December 04, 2021
From Motley Fool
From Motley Fool
Jim Cramer Shares His Thoughts On Chegg, Bristol-Myers Squibb And More
November 30, 2021
From Benzinga
Will This Beaten-Down Stock Bounce Back? 3 Things to Know
November 29, 2021
From Motley Fool
Do CRISPR Therapeutics and Intellia Face a Big Safety Risk?
November 21, 2021
From Motley Fool
Better Buy: Vertex Pharmaceuticals vs. CRISPR
November 20, 2021
From Motley Fool
2 Beaten-Down Growth Stocks You Can Buy Right Now
November 17, 2021
From Motley Fool
Being First Is Not Enough For Crispr Therapeutics
November 15, 2021
From InvestorPlace
The Key Behind Vertex's Great Q3 Results
November 11, 2021
From Motley Fool
Cathie Wood's Buying Beam Therapeutics -- Should You?
November 09, 2021
From Motley Fool
Can Vertex Make Billions With a New Game-Changing Treatment? The Answer May Be Just Ahead
November 05, 2021
From Motley Fool
Why CRISPR Therapeutics Stock Fell 18.4% in October
November 04, 2021
From Motley Fool
Why Vertex Is Striking Another Gene-Editing Deal With a Company Not Named CRISPR Therapeutics
November 04, 2021
From Motley Fool
3 No-Brainer Biotech Stocks to Buy in November
November 04, 2021
From Motley Fool
5 Biotech Stocks With 105% to 386% Upside, According to Wall Street
November 03, 2021
From Motley Fool
Could This Drug Become Vertex Pharmaceuticals' Next Blockbuster?
November 02, 2021
From Motley Fool
3 Stocks Cathie Wood Is Buying That You Might Want to Consider Too
October 26, 2021
From Motley Fool
Biotech Buyouts That Would Be Great for Investors
October 22, 2021
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.